Sönke Holtorf, PhD
DIRECTOR HBC | DIRECTORATE 188.8.131.52, EUROPEAN PATENT OFFICE
Since 2012, Dr Sönke Holtorf is serving as director in biotechnology of sector HBC (Health Biotech and Chemistry) at the European Patent Office (EPO). Sönke is a former examiner with 15 years’ experience in the field of biotechnology. To this level of expertise, should be added his PhD and post-doctoral studies, both in the field of plant molecular biology. Sönke's directorate specializes in examination of patent applications concerning protein- and DNA-based diagnosis, vaccines, immunology, iRNA therapy, and microbiology.
4:00 PM - 4:45 PM (EDT)
Wednesday, June 16
The emerging field of CAR T cell therapy has the potential to change the way we treat cancer. And…